A LyP on the Lip: A Rare Case of Cutaneous T Cell Lymphomatoid Papulosis (LyP) After Kidney Transplant

Introduction: LyP is a rare T-cell lymphoma found in less than 2% of patients annually and even rarer in kidney transplant recipients. Mucosal involvement is uncommon and has been described only in a few case reports. This case describes an unusual presentation of this lymphoproliferative disorder that requires a high index of clinical suspicion. Case Description: A 71-year-old female with a 30-pack-year smoking history and ESKD from diabetic nephropathy underwent a Deceased Donor Kidney Transplant with Thymoglobulin induction. Maintenance immunosuppression included Belatacept, Tacrolimus, Mycophenolate, and Prednisone. 1.5 years post-transplant, she reported a painless non-healing gingival ulcer (image A). Progression of ulceration and negative HSV swab led to a biopsy, which revealed Atypical T/NK cell infiltrate, CD30(+) -consistent with LyP (Image B and D). Viral stains, including EBV, were negative. PET-CT showed focal avidity corresponding to the site of the lesion (Image C). There was no lymph node or sinus involvement. Immunosuppression was modulated to only Belatacept and prednisone. A shared decision was made to continue active surveillance and forego active therapy, given the indolent nature of the disease, and the patient's overall morbidity. At 1 year follow up, the patient and allograft continue to do well with no evidence of disease recurrence. Discussion: LyP is characterized by localized papulonodular lesions and is often indolent. As the disease evolves, systemic manifestations may become clinically apparent. Prompt recognition of LyP and timely adjustment of immunosuppression regimens can help decrease morbidity, limit cytotoxic radiation, and preserve allograft health.(A) Mucosal ulcer (B) Biopsy specimen (H&E) with diffuse pleomorphic lymphoid cells (C) PET-CT of the head and neck with focal avidity pointed by the blue arrows (D) Immunohistochemistry with positive staining for CD2

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2025-10-01
DOI
https://doi.org/10.1681/asn.2025enxwagw8
Primary Topic
Cutaneous lymphoproliferative disorders research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A LyP on the Lip: A Rare Case of Cutaneous T Cell Lymphomatoid Papulosis (LyP) After Kidney Transplant

Journal of the American Society of Nephrology
Cutaneous lymphoproliferative disorders research
article

A LyP on the Lip: A Rare Case of Cutaneous T Cell Lymphomatoid Papulosis (LyP) After Kidney Transplant

article en

Abstract

Introduction: LyP is a rare T-cell lymphoma found in less than 2% of patients annually and even rarer in kidney transplant recipients. Mucosal involvement is uncommon and has been described only in a few case reports. This case describes an unusual presentation of this lymphoproliferative disorder that requires a high index of clinical suspicion. Case Description: A 71-year-old female with a 30-pack-year smoking history and ESKD from diabetic nephropathy underwent a Deceased Donor Kidney Transplant with Thymoglobulin induction. Maintenance immunosuppression included Belatacept, Tacrolimus, Mycophenolate, and Prednisone. 1.5 years post-transplant, she reported a painless non-healing gingival ulcer (image A). Progression of ulceration and negative HSV swab led to a biopsy, which revealed Atypical T/NK cell infiltrate, CD30(+) -consistent with LyP (Image B and D). Viral stains, including EBV, were negative. PET-CT showed focal avidity corresponding to the site of the lesion (Image C). There was no lymph node or sinus involvement. Immunosuppression was modulated to only Belatacept and prednisone. A shared decision was made to continue active surveillance and forego active therapy, given the indolent nature of the disease, and the patient's overall morbidity. At 1 year follow up, the patient and allograft continue to do well with no evidence of disease recurrence. Discussion: LyP is characterized by localized papulonodular lesions and is often indolent. As the disease evolves, systemic manifestations may become clinically apparent. Prompt recognition of LyP and timely adjustment of immunosuppression regimens can help decrease morbidity, limit cytotoxic radiation, and preserve allograft health.(A) Mucosal ulcer (B) Biopsy specimen (H&E) with diffuse pleomorphic lymphoid cells (C) PET-CT of the head and neck with focal avidity pointed by the blue arrows (D) Immunohistochemistry with positive staining for CD2

Journal of the American Society of NephrologyVol. 36(10S)
University of Virginia Health System (US)
Good health and well-being
Openalex Percentile: Top 29%
Cutaneous lymphoproliferative disorders research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A LyP on the Lip: A Rare Case of Cutaneous T Cell Lymphomatoid Papulosis (LyP) After Kidney Transplant · Journal of the American Society of Nephrology (2025) | TGRS Research Map | TGRS